We specialize in supplying high - quality xce tirzepatide (also known as LY3298176) peptide, a dual glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptor agonist. Offered in 2mg, 5mg, and 10mg vial options, with 99.9% purity and pharmacy - grade quality, it is designed exclusively for research use (not for personal use).
xce tirzepatide (CAS 2023788 - 19 - 2, molecular formula C225H348N48O68) appears as a white powder. Its dual - agonist mechanism makes it valuable for type 2 diabetes and weight management research. In pre - clinical/clinical models, it outperforms peptides like Dulaglutide in glucose control and weight loss. The SURMOUNT - 1 trial (research reference) showed 5mg, 10mg, 15mg doses led to 15%, 19.5%, 20.9% weight loss over 72 weeks.
The sequence of xce tirzepatide resembles semaglutide, with a PEG - modified lys side chain enhancing water solubility for research use. It has FDA Fast Track designation (research - drug development reference) to accelerate obesity - related drug research.
We offer xce tirzepatide with factory - direct, wholesale, and custom supply options. Packaged as 10 vials/box (MOQ 10 vials), store it in a cold, dry, dark place; avoid repeated freeze - thaw, air/light exposure, long - term solution storage, and aliquot per experimental needs.